Provenienza dei contatti di primo grado di Michael Blind
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
NascaCell Technologies AG
NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany.
3
| Extinct | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael Blind tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
TRADE & VALUE AG | Investment Managers | Chairman | |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Xantos AG
Xantos AG Pharmaceuticals: MajorHealth Technology Xantos AG is a functional biology and drug discovery company developing biopharmaceuticals in the areas of cancer and metabolic diseases. Its business model is to develop drug discovery pipelines based on the validated targets and leads generated by its proprietary through target identification and validation system and to form indication specific joint research and development collaborations with pharmaceutical and biotechnology companies. It also offers customers its proprietary technology and cDNA/siRNA screening tools for research service deals. The company is headquartered in Munich, Germany. | Pharmaceuticals: Major | Founder | |
Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree | |
SPEXIS AG | Pharmaceuticals: Major | Chief Operating Officer | |
Excalibur Capital AG
Excalibur Capital AG Financial ConglomeratesFinance Excalibur Capital AG engages in the acquisition, holding, and sale of securities and precious metals. The company was founded on November 24, 1998 and is headquartered in Oldenburg, Germany. | Financial Conglomerates | Director/Board Member | |
Aventis Pharma AG | Corporate Officer/Principal | ||
Epidauros Biotechnologie AG
Epidauros Biotechnologie AG Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million. | Miscellaneous Commercial Services | President | |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director of Finance/CFO | |
FONTERELLI GMBH & CO. KGAA | Food Distributors | Director/Board Member | |
University of Bremen | College/University | Graduate Degree | |
Hoechst Pharmaceuticals Ltd. | Corporate Officer/Principal | ||
Inspire AG
Inspire AG Financial ConglomeratesFinance Inspire AG invests in small caps. It engages in the investment in funded projects and small enterprises with growth potentials such as those in turnaround situations. The firm also invests in the radio frequency identification and renewable energy sector. It provides its portfolio companies with restructuring assistance and funds for the implementation of new technologies and product introduction. The company is headquartered in Salzkotten, Germany. | Financial Conglomerates | Director/Board Member | |
SC24.com AG
SC24.com AG Specialty StoresRetail Trade Part of Sajama Capital GmbH, SC24.com AG is a sporting German goods company that offers a variety of new football, running, fitness, outdoor, and lifestyle articles from trendy brands. The company is based in Krumbach, Germany. Customers can purchase items from the ellesse and Happy Socks online shops at SC24.com, with fast shipping and the option to buy on account and enjoy free returns. | Specialty Stores | Director/Board Member | |
Tube Pharmaceuticals GmbH
Tube Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Tube Pharmaceuticals GmbH develops a new class of anti cancer drugs. Its products include Tubulysins and their synthetic analogs and next generation Epothilones. The company assets are natural product classes and their synthetic analogues comprising a product platform with multiple partnering and development opportunities. It focuses on synthetic substances for the cancer therapy, derived from natural substances. The company was founded in 2011 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director of Finance/CFO | |
Dornisch Research AG | Chairman | ||
HvS-Consulting AG
HvS-Consulting AG Information Technology ServicesTechnology Services HvS-Consulting AG specializes in security consulting, assessments, adversary simulations, incident response, and security awareness. The company is based in Garching, Germany. The German company offers risk management for information security to identify assets and risks, and implement measures. The company also provides comprehensive training for employees, executives, and IT personnel on cyber security. Additionally, they help ensure the smooth operation of businesses through a Business Continuity Management System (BCMS). | Information Technology Services | Director/Board Member | |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Medical/Nursing Services | Director of Finance/CFO | |
Proterris, Inc.
Proterris, Inc. Pharmaceuticals: MajorHealth Technology Proterris, Inc. manufactures applications of low-dose carbon monoxide. It develops carbon monoxide for delayed graft function in renal transplant recipients and idiopathic pulmonary fibrosis. The company was founded by Jeffrey Wager and Joseph Wager and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Censhare AG
Censhare AG Packaged SoftwareTechnology Services Censhare AG develops online platform which pools all marketing and communications content within one information-centric system. The company is headquartered in Munich, Germany. | Packaged Software | Director of Finance/CFO | |
Advertima AG
Advertima AG Packaged SoftwareTechnology Services Advertima AG is a Swiss computer vision company that digitizes customers in stores and transforms grocery stores into a profitable retail media network. The company is based in St. Gallen, Switzerland. The company provides insights from their success stories and offer information on retail media and performance media data through their news and blog articles. Advertima was founded in 2016 by Mario Siano, Simon Ebner, Iman Nahvi, and Amir Nahvi, with Iman Nahvi serving as the CEO since 2016. | Packaged Software | Director of Finance/CFO | |
CANNABIS.DE MEDIA AG | Finance/Rental/Leasing | Director/Board Member | |
FONTERELLI SPAC 3 AG | Financial Conglomerates | Director/Board Member | |
Granite Bio AG | Director of Finance/CFO | ||
a-on AG | Chairman | ||
MAX8 AG | Chairman |
Statistiche
Distribuzione geografica
Germania | 22 |
Stati Uniti | 4 |
Svizzera | 4 |
Francia | 2 |
Regno Unito | 2 |
Settori
Health Technology | 8 |
Finance | 7 |
Commercial Services | 4 |
Technology Services | 4 |
Consumer Services | 3 |
Posizioni
Director/Board Member | 11 |
Director of Finance/CFO | 9 |
Corporate Officer/Principal | 5 |
Chairman | 5 |
President | 2 |
Contatti più connessi
Insiders | |
---|---|
Stephan Wehselau | 13 |
Wolfgang Weilermann | 13 |
Manfred Zoltobrocki | 7 |
- Borsa valori
- Insiders
- Michael Blind
- Connessioni Società